Keywords: Pfizer, ChemRar, R&D partnership, Russia

Pfizer and ChemRar plan to explore innovative R&D partnership in Russia

Article | 01 July 2011

Print This

Following in the footsteps of Switzerland’s Roche, global drugs behemoth Pfizer (NYSE: PFE) has signed a Memorandum of ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in